Deciding how to treat your breast cancer can be a very difficult and personal decision. Dr. Cindy Matsen, breast surgeon at Huntsman Cancer Institute, says it’s easy for women who begin initial ...

Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...

“You know that phrase, ‘third time’s the charm?’ ” Marilene Nevins asks. Well, not always. In 1997, a suspicious mass was found in Nevins’ right breast. “I nicknamed that one Mickey,” she says. “You ...

Lumpectomy is the gold standard for breast cancer surgery, says Kirstyn E. Brownson, MD, a surgical breast oncologist at Huntsman Cancer Institute. We asked Dr. Brownson to explain what a lumpectomy ...

DEAR MAYO CLINIC: I understand surgery is often included as part of the treatment plan for breast cancer. If I'm a candidate for lumpectomy but am also considering a mastectomy, what are some things I ...

A new U.S. study examining survival rates for women with early stage breast cancer found that surgery such as lumpectomy that preserves the rest of the breast may offer survival odds as good as, or ...

The associate director for surgery at the Dubin Breast Center at Mount Sinai, Christina Weltz is a surgeon who specializes in malignant and benign breast issues. She does about 150 breast cancer ...

For those with localized breast cancer, surgical options may include either lumpectomy or mastectomy, and patients have free rein about which to choose. Star Mackenzie Burruto had just gotten off the ...

A 31-year-old woman underwent a right lumpectomy and sentinel lymph node sampling for a breast mass. Pathology showed a 21 x 11 mm medullary carcinoma of the breast, with clear margins; lymph nodes ...

(02-06) 10:47 PST SAN FRANCISCO-- For decades, clinical trials and other studies have shown that women with early-stage breast cancer have the same survival odds whether they choose to have a surgery ...

Molecular and genomic predictors of response to single-agent doxorubicin (ADR) versus single-agent docetaxel (DOC) in primary breast cancer (PBC). Background: In women 70 years of age or older with ...